Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
10.51
+0.05 (0.48%)
At close: Feb 13, 2026

SHE:002873 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
169.43118.16138.24100.6772.48330.09
Trading Asset Securities
0.10.120.090.1180118
Cash & Short-Term Investments
169.53118.28138.33100.78152.48448.09
Cash Growth
23.91%-14.49%37.26%-33.91%-65.97%146.67%
Accounts Receivable
263.85325.67250.54261.96282.72249.96
Other Receivables
24.122.0948.2242.1221.5218.16
Receivables
287.95347.77298.76304.08304.24268.13
Inventory
180.45145.48184.33183.34118.7786.82
Other Current Assets
15.95.281522.4411.349.85
Total Current Assets
653.83616.81636.43610.65586.83812.88
Property, Plant & Equipment
686.4708.83706.3593.75463.94381.09
Long-Term Investments
530.34412.07383.27461.57312.5183.64
Other Intangible Assets
108.33108.9683.5286.187.5179.51
Long-Term Deferred Tax Assets
10.6610.0610.3313.4611.2612.6
Long-Term Deferred Charges
98.4290.3688.4570.3958.6762.39
Other Long-Term Assets
4.953.413.53.63.713.81
Total Assets
2,0931,9511,9121,8401,5241,536
Accounts Payable
106.8983.36105.0895.6764.8944.81
Accrued Expenses
22.8848.9131.839.7153.8543.38
Short-Term Debt
59.02306.24366.93317.37268.34402.02
Current Portion of Long-Term Debt
73.5420.826.035.01-2.46
Current Portion of Leases
-4.974.161.4--
Current Income Taxes Payable
16.620.0302.294.723.71
Current Unearned Revenue
0.660.52113.8615.367.9
Other Current Liabilities
22.1616.5520.4226.434.079.36
Total Current Liabilities
301.76481.38555.42501.69441.23513.64
Long-Term Debt
463.24221.4195.54156.68154.79159.95
Long-Term Leases
6.156.779.355.726.65-
Long-Term Unearned Revenue
24.1223.5820.8322.1524.5124
Long-Term Deferred Tax Liabilities
33.8222.1116.7227.993.386.55
Other Long-Term Liabilities
0.530.550.593.363.423.5
Total Liabilities
829.62755.79798.47717.59633.98707.64
Common Stock
244.1244.1231.49231.97164.05117.15
Additional Paid-In Capital
282.35282.35179.72187220.67281.76
Retained Earnings
667.39665.32637.57579.88490.94404.35
Treasury Stock
-75.3-75.3-9.54-17.61-27.81-35.6
Comprehensive Income & Other
144.7778.2474.09140.6942.6160.63
Total Common Equity
1,2631,1951,1131,122890.44828.3
Shareholders' Equity
1,2631,1951,1131,122890.44828.3
Total Liabilities & Equity
2,0931,9511,9121,8401,5241,536
Total Debt
601.95560.18602.01486.17429.79564.43
Net Cash (Debt)
-432.42-441.9-463.68-385.39-277.31-116.35
Net Cash Per Share
-1.88-2.01-1.90-1.58-1.13-0.48
Filing Date Shares Outstanding
235.3235.3231.4231.89228.31225.3
Total Common Shares Outstanding
235.3235.3231.4231.89228.31225.3
Working Capital
352.07135.4381108.96145.59299.24
Book Value Per Share
5.375.084.814.843.903.68
Tangible Book Value
1,1551,0861,0301,036802.93748.78
Tangible Book Value Per Share
4.914.614.454.473.523.32
Buildings
-628.65639.78369.03327.11293.66
Machinery
-177.35167.14121.4792.5284.84
Construction In Progress
-55.8133.72228.36151.2299.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.